Astellas to Acquire Ganymed in Deal Worth $1.4 Billion
By

By
Astellas Pharma has agreed to acquire Ganymed Pharmaceuticals, a biopharmaceutical company based in Mainz, Germany focused on antibody therapeutics for cancer, for EUR 422 million ($462 million). The transaction would…

Daiichi Sankyo Forms Licensing Pact for Abuse-Deterrent Opioid
By

By
Daiichi Sankyo has formed a strategic collaboration with Inspirion Delivery Sciences, a Basking Ridge, New Jersey-based specialty pharmaceutical company, to commercialize MorphaBond (morphine sulfate) extended-release tablets, CII, an abuse-deterrent opioid…

Sanofi Forms Zika Vaccine Research Pact
By

By
Sanofi and its vaccines global business unit, Sanofi Pasteur, have formed a collaboration with the Oswaldo Cruz Foundation, via Bio-Manguinhos/Fiocruz, the foundation’s immuno-biological technology institute, and the Walter Reed Army…

GSK Forms Pact for Urinary Tract Infection Drug
By

By
GlaxoSmithKline (GSK) has formed a collaboration with Fimbrion Therapeutics, a start-up biotechnology company based in St. Louis, Missouri, to develop a small-molecule drug for the treatment and prevention of urinary…

Sun Pharma To Acquire Ocular Technologies
By

By
Sun Pharmaceutical Industries, a Mumbai, India-headquartered pharmaceutical company, has agreed to acquire Ocular Technologies Sarl, a wholly owned subsidiary of Auven Therapeutics, a private-equity firm with operations in Lausanne, Switzerland,…

Allergan, Endo, and Mayne Pharma Lead Drug Approvals
By

By
A roundup of the latest drug approvals, including from the pharmaceutical majors, featuring news from Allergan, Endo, and Mayne Pharma. Editor’s Note: This article is updated on a continuous basis for…

Biogen, Merck KGaA, Novartis and Sanofi Lead Pipeline News
By

By
A roundup of the latest market developments from the pipelines of the pharmaceutical majors and other related news, featuring news from Biogen, Merck KGaA, Novartis, and Sanofi. Editor’s Note: This…

Nordic Nanovector, Heidelberg Pharma in ADC Pact
By

By
Nordic Nanovector, an Oslo, Norway-based biotechnology company focused on hematology and oncology, has formed a collaboration with Heidelberg Pharma, the Ladenburg, Germay-based subsidiary of the Munich, Germany-headquartered biopharmaceutical company, Wilex,…

Bayer, Cube Launch Collaborative Space for Start-Ups
By

By
Bayer, a founding member and life sciences partner of Cube, a start-up initiative headquartered in Berlin, Germany, has launched a cooperation space in Berlin with Cube and other representatives of…

Roche, Novogen in Licensing Deal for Brain Cancer Drug
By

By
Genentech, a member of the Roche Group, has signed a worldwide licensing agreement with Novogen, an oncology-focused biotechnology company headquartered in New South Wales, Australia, to develop and commercialize GDC-0084,…